PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants

CompletedOBSERVATIONAL
Enrollment

257

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

September 30, 2020

Study Completion Date

June 30, 2021

Conditions
HepatoblastomaHepatic Hemangioendothelioma
Interventions
DIAGNOSTIC_TEST

PIVKA-II

Serum samples are tested for tumor markers including PIVKA-II, AFP, and biochemical tests.

Trial Locations (1)

200127

Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Chidren's Hospital of Fudan University

UNKNOWN

collaborator

Chongqing Children's Hospital, Chongqing Medical University

UNKNOWN

collaborator

Children's Hospital of Nanjing Medical University

OTHER

collaborator

Qilu Children's Hospital of Shandong University

OTHER

collaborator

Anhui Children's Hospital

UNKNOWN

collaborator

The First Affiliated Hospital of Anhui Medical University

OTHER

collaborator

Zhengzhou Children's Hospital

UNKNOWN

collaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

lead

Shanghai Children's Medical Center

OTHER

NCT03645655 - PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants | Biotech Hunter | Biotech Hunter